https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Grants Accelerated Approval to First Treatment for Barth Syndrome

FDA Grants Accelerated Approval to First Treatment for Barth Syndrome

The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first treatment for Barth syndrome, in patients weighing at least 30 kg.

administrator

Related Articles